DOAC Cuts Stroke Risk From Subclinical Afib
(MedPage Today) -- PHILADELPHIA -- For patients with subclinical atrial fibrillation (Afib, AF) detected by their pacemaker or defibrillator, direct oral anticoagulation brought their already low stroke risk even lower -- but at a cost in bleeding... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 13, 2023 Category: Cardiology Source Type: news
Promising Debut for CRISPR Gene Editing Therapy for LDL Lowering
(MedPage Today) -- PHILADELPHIA -- A DNA base editing therapy, intended for lifelong lowering of LDL cholesterol, passed initial tests in people with severe, advanced atherosclerotic cardiovascular disease (ASCVD).
According to interim results... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 12, 2023 Category: Cardiology Source Type: news
Double Defibrillator More Effective for Obese Afib Patients
(MedPage Today) -- PHILADELPHIA -- For atrial fibrillation (Afib) patients with obesity, a second set of defibrillation pads for dual direct current cardioversion safely improved the success of the procedure, a randomized trial showed.
Only... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 12, 2023 Category: Cardiology Source Type: news
No Aspirin Needed After LVAD, ARIES-HM3 Trial Says
(MedPage Today) -- PHILADELPHIA -- Dropping aspirin from the antithrombotic regimen after HeartMate 3 left ventricular assist device (LVAD) implantation appeared safer than the usual combination approach in the ARIES-HM3 trial.
Atop warfarin... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 12, 2023 Category: Cardiology Source Type: news
And for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetes
(MedPage Today) -- PHILADELPHIA -- An enormous swath of Americans can be expected to get secondary cardiovascular prevention benefits from weekly semaglutide (Wegovy) injections based on the SELECT trial.
Even in the absence of diabetes, overweight... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 11, 2023 Category: Cardiology Source Type: news
Transfusion Thresholds Square Off in Acute Myocardial Infarction
(MedPage Today) -- PHILADELPHIA -- For acute myocardial infarction (MI) patients with anemia, being more liberal with blood transfusion thresholds didn't significantly impact risk of recurrent heart attack or death in the MINT trial, although... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 11, 2023 Category: Cardiology Source Type: news
Pregnant Patients With High Autoantibody Levels Need Fetal Heart Monitoring
(MedPage Today) -- SAN DIEGO -- Frequent fetal heart monitoring is not needed in every pregnant woman testing positive for anti-SSA/anti-Ro autoantibodies, but it's definitely advisable for those with high titers, interim results of a new trial... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 11, 2023 Category: Cardiology Source Type: news
Seek and Ye Shall Find Afib in Stroke Survivors
(MedPage Today) -- In 2023, stroke remains the fifth leading cause of death in the U.S. and a leading cause of long-term disability. After a stroke, the 5-year risk of myocardial infarction or vascular death is 17% and the 4-year risk of recurrent... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 8, 2023 Category: Cardiology Source Type: news
Another Xenotransplant Death; Many Unaware of HF Diagnosis; Full-Body TAVR Protector
(MedPage Today) -- The second recipient of a pig heart xenotransplant died 6 weeks after the procedure, following signs of organ rejection, University of Maryland Medical Center announced.
Could the benefits of revascularization for obstructive... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 7, 2023 Category: Cardiology Source Type: news
Novel Aldosterone Synthase Inhibitor Cuts Albuminuria in Phase II Trial
(MedPage Today) -- PHILADELPHIA -- An oral investigational aldosterone synthase inhibitor (ASI) cut albuminuria by nearly 40% in people in chronic kidney disease (CKD) in a phase II trial.
The 10-mg dose of ASI BI 690517 yielded an average 37... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 7, 2023 Category: Cardiology Source Type: news
Heart Injuries Suggest Reconsideration of Holding BP Meds for Surgery
(MedPage Today) -- The practice of taking some patients briefly off their antihypertensive medications before non-cardiac surgery did not work as intended, and in fact led to excess acute hypertension in the SPACE trial.
Myocardial injury rates... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 6, 2023 Category: Cardiology Source Type: news
ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Disease
(MedPage Today) -- PHILADELPHIA -- A low-dose, investigational endothelin A receptor antagonist paired with an SGLT2 inhibitor reduced albuminuria in patients with chronic kidney disease (CKD) in the phase IIb ZENITH-CKD trial.
By week 12 of... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 5, 2023 Category: Cardiology Source Type: news
Rampant Stent Overuse; Hot Tub Heart Risks Revisited; Cardiologist Runs for Office
(MedPage Today) -- The American Heart Association said it is officially joining efforts to create a new American Board of Cardiovascular Medicine specific to cardiovascular physicians, alongside other professional societies.
One Texas hospital... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 1, 2023 Category: Cardiology Source Type: news
Chinese Compound for MI?; Knee Pain Management
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 28, 2023 Category: Cardiology Source Type: news
Tricuspid Valve Replacement Safe, Effective in Pivotal Trial
(MedPage Today) -- SAN FRANCISCO -- The investigational Evoque transcatheter tricuspid valve replacement (TTVR) prosthesis appeared safe and beneficial in initial pivotal trial data.
The major adverse event rate of 27.4% was less than the expected... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 27, 2023 Category: Cardiology Source Type: news
